Portal de Periódicos da CAPES

What Is CBA/CEA, and Why Are They Doing This to Us?

1980; Massachusetts Medical Society; Volume: 303; Issue: 16 Linguagem: Inglês

10.1056/nejm198010163031611

1533-4406

Victor R. Fuchs,

Delphi Technique in Research

Many physicians approach cost-benefit and cost-effectiveness analysis (CBA/CEA) with something akin to what Sir James Frazer described as "the awe and dread with which the untutored savage contemplates his mother-in-law." 1 This is unwise and unnecessary. The recently published report of the Office of Technology Assessment2 makes it clear that CBA/CEA is neither a purgative nor a panacea nor a placebo. This well-written, carefully documented study explains the strengths and weaknesses of CBA/CEA, reviews attempts to apply it in health care, and offers a set of policy options and recommendations for future action. The report deserves the attention of physicians and . . .